EUVIMEDEUVIMED entdecken
BeobachtungsstudieVergleichsstudieOpen Access · CC BY-NC 4.0

Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study

Ji-Hyeon Kim, Jae-Sik Nam, Wan-Woo Seo, Kyung-Woon Joung, Ji-Hyun Chin, Wook-Jong Kim, Dae-Kee Choi, In-Cheol Choi

Korean Journal of Anesthesiology · 2024

DOI: 10.4097/kja.24138 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Korean Journal of Anesthesiology, 2024. Verfasst von Ji-Hyeon Kim und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea. Hauptthemen laut MEDLINE: Dexmedetomidine, Propensity Score, Transcatheter Aortic Valve Replacement, Hypnotics and Sedatives. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Minimalist transcatheter aortic valve replacement (TAVR) under monitored anesthesia care (MAC) emphasizes early recovery. Remimazolam is a novel benzodiazepine with a short recovery time. This study hypothesized that remimazolam is non-inferior to dexmedetomidine in terms of recovery after TAVR.

Methods

In this retrospective observational study, remimazolam was compared to dexmedetomidine in patients who underwent TAVR under MAC at a tertiary academic hospital between July 2020 and July 2022. The primary outcome was timely recovery after TAVR, defined as discharge from the intensive care unit within the first day following the procedure. Propensity score matching was used to compare timely recovery between remimazolam and dexmedetomidine, applying a non-inferiority margin of -10%.

Results

The study included 464 patients, of whom 218 received remimazolam and 246 received dexmedetomidine. After propensity score matching, 164 patients in each group were included in the analysis. Regarding timely recovery after TAVR, remimazolam was non-inferior to dexmedetomidine (152 of 164 [92.7%] in the remimazolam group versus 153 of 164 [93.3%] in the dexmedetomidine group, risk difference [95% CI]: −0.6% [−6.7%, 5.5%]). The use of remimazolam was associated with fewer postoperative vasopressors/inotropes (21 of 164 [12.8%] vs. 39 of 164 [23.8%]) and temporary pacemakers (TPMs) (76 of 164 [46.3%] vs. 108 of 164 [65.9%]) compared to dexmedetomidine.

Conclusions

In patients undergoing TAVR under MAC, remimazolam was non-inferior to dexmedetomidine in terms of timely recovery. Remimazolam may be associated with better postoperative recovery profiles, including a lesser need for vasopressors/inotropes and TPMs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

DexmedetomidinePropensity ScoreTranscatheter Aortic Valve ReplacementHypnotics and SedativesHumansMaleFemaleRetrospective StudiesAgedAged, 80 and overBenzodiazepinesAnesthesia Recovery Period

Stichwörter der Autor:innen

BenzodiazepinesConscious sedationDexmedetomidineHeart valve prosthesis implantationPropensity scoreRemimazolam

Substanzen

DexmedetomidineremimazolamHypnotics and SedativesBenzodiazepines

Autor:innen und Institutionen

  • Department of Anesthesiology and Pain Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea.

Zitieren

APA

Kim, J. H., Nam, J. S., Seo, W. W., Joung, K. W., Chin, J. H., Kim, W. J., Choi, D. K., & Choi, I. C. (2024). Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study. Korean Journal of Anesthesiology. https://doi.org/10.4097/kja.24138

Vancouver

Kim JH, Nam JS, Seo WW, Joung KW, Chin JH, Kim WJ, et al. Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study. Korean Journal of Anesthesiology. 2024. doi:10.4097/kja.24138

BibTeX
@article{Kim2024,
  author = {Kim, Ji-Hyeon and Nam, Jae-Sik and Seo, Wan-Woo and Joung, Kyung-Woon and Chin, Ji-Hyun and Kim, Wook-Jong and Choi, Dae-Kee and Choi, In-Cheol},
  title = {Effects of remimazolam versus dexmedetomidine on recovery after transcatheter aortic valve replacement under monitored anesthesia care: a propensity score-matched, non-inferiority study},
  journal = {Korean Journal of Anesthesiology},
  year = {2024},
  doi = {10.4097/kja.24138}
}
Kostenlos starten →